The purpose of our present study was to examine the possible regulatory role of ID1 and ETS transcription factors in melanoma progression, especially since they are known to influence both the CDKN2A/p16 pathway and angiogenesis regulation (Yates et al, 1999; Alani et al, 2001). This evidence concerns the gene ID1 and melanoma.